[PHARMA] QoQ TTM Result on 30-Sep-2022 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- -25.17%
YoY- 52.53%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 3,516,589 3,428,957 3,510,677 3,359,675 4,567,669 4,983,690 4,815,015 -18.94%
PBT -607,271 -609,092 -580,846 182,637 265,267 282,990 277,075 -
Tax -22,459 -22,048 -24,204 -58,325 -100,008 -104,757 -104,870 -64.30%
NP -629,730 -631,140 -605,050 124,312 165,259 178,233 172,205 -
-
NP to SH -631,164 -632,403 -607,317 122,548 163,766 176,748 172,150 -
-
Tax Rate - - - 31.93% 37.70% 37.02% 37.85% -
Total Cost 4,146,319 4,060,097 4,115,727 3,235,363 4,402,410 4,805,457 4,642,810 -7.28%
-
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div 7,859 14,409 24,889 90,356 108,678 121,759 121,748 -83.98%
Div Payout % 0.00% 0.00% 0.00% 73.73% 66.36% 68.89% 70.72% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
NOSH 1,310,208 1,310,208 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 0.05%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -17.91% -18.41% -17.23% 3.70% 3.62% 3.58% 3.58% -
ROE 0.00% 0.00% 0.00% 29.79% 40.33% 42.70% 38.22% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 268.40 261.71 268.00 256.47 348.69 380.45 367.74 -18.98%
EPS -48.17 -48.27 -46.36 9.36 12.50 13.49 13.15 -
DPS 0.60 1.10 1.90 6.90 8.30 9.30 9.30 -83.99%
NAPS -0.105 -0.109 -0.19 0.314 0.31 0.316 0.344 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 244.00 237.92 243.59 233.11 316.93 345.79 334.09 -18.94%
EPS -43.79 -43.88 -42.14 8.50 11.36 12.26 11.94 -
DPS 0.55 1.00 1.73 6.27 7.54 8.45 8.45 -83.89%
NAPS -0.0955 -0.0991 -0.1727 0.2854 0.2818 0.2872 0.3125 -
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 0.37 0.285 0.545 0.515 0.595 0.755 0.74 -
P/RPS 0.14 0.11 0.20 0.20 0.17 0.20 0.20 -21.21%
P/EPS -0.77 -0.59 -1.18 5.51 4.76 5.60 5.63 -
EY -130.20 -169.36 -85.07 18.17 21.01 17.87 17.77 -
DY 1.62 3.86 3.49 13.40 13.95 12.32 12.57 -74.58%
P/NAPS 0.00 0.00 0.00 1.64 1.92 2.39 2.15 -
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 11/08/23 18/05/23 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 -
Price 0.42 0.38 0.44 0.55 0.595 0.72 0.76 -
P/RPS 0.16 0.15 0.16 0.21 0.17 0.19 0.21 -16.62%
P/EPS -0.87 -0.79 -0.95 5.88 4.76 5.34 5.78 -
EY -114.70 -127.02 -105.37 17.01 21.01 18.74 17.30 -
DY 1.43 2.89 4.32 12.55 13.95 12.92 12.23 -76.18%
P/NAPS 0.00 0.00 0.00 1.75 1.92 2.28 2.21 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment